世界の消化管間質腫瘍（GIST）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2501 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、消化管間質腫瘍（GIST）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、標的療法、放射線療法、化学療法、アブレーション、塞栓術、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・消化管間質腫瘍（GIST）治療の市場動向 ・企業の競争状況、市場シェア ・消化管間質腫瘍（GIST）治療の種類別市場規模（手術、標的療法、放射線療法、化学療法、アブレーション、塞栓術、その他） ・消化管間質腫瘍（GIST）治療の用途別市場規模（病院、診療所、外来手術センター、その他） ・消化管間質腫瘍（GIST）治療の北米市場規模2016-2027（アメリカ、カナダ） ・消化管間質腫瘍（GIST）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・消化管間質腫瘍（GIST）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・消化管間質腫瘍（GIST）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・消化管間質腫瘍（GIST）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Bayer、Novartis、Immunicum、Roche、AB Science、Arog Pharmaceuticals、Boston Biomedical、Sun Pharmaceutical、Natco Pharma） ・結論

A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.

Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market
The global Gastrointestinal Stromal Tumors (GISTs) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastrointestinal Stromal Tumors (GISTs) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastrointestinal Stromal Tumors (GISTs) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastrointestinal Stromal Tumors (GISTs) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastrointestinal Stromal Tumors (GISTs) Treatment market.

Global Gastrointestinal Stromal Tumors (GISTs) Treatment Scope and Market Size
Gastrointestinal Stromal Tumors (GISTs) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Stromal Tumors (GISTs) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Targeted Therapy
Radiation Therapy
Chemotherapy
Ablation
Embolization
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Bayer
Novartis
Immunicum
Roche
AB Science
Arog Pharmaceuticals
Boston Biomedical
Sun Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Targeted Therapy
1.2.4 Radiation Therapy
1.2.5 Chemotherapy
1.2.6 Ablation
1.2.7 Embolization
1.2.8 Others
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Perspective (2016-2027)
2.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Growth Trends by Regions
2.2.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Industry Dynamic
2.3.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Trends
2.3.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Drivers
2.3.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Challenges
2.3.4 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumors (GISTs) Treatment Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumors (GISTs) Treatment Players by Revenue (2016-2021)
3.1.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue
3.4 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue in 2020
3.5 Gastrointestinal Stromal Tumors (GISTs) Treatment Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Product Solution and Service
3.7 Date of Enter into Gastrointestinal Stromal Tumors (GISTs) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Stromal Tumors (GISTs) Treatment Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Forecasted Market Size by Type (2022-2027)

5 Gastrointestinal Stromal Tumors (GISTs) Treatment Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2016-2027)
6.2 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
6.2.1 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021)
6.2.2 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2022-2027)
6.2.3 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2027)
6.3 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application
6.3.1 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2021)
6.3.2 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2022-2027)
6.3.3 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2027)
6.4 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country
6.4.1 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2016-2021)
6.4.2 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2016-2027)
7.2 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
7.2.1 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2027)
7.3 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application
7.3.1 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2027)
7.4 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country
7.4.1 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
8.2.1 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application
8.3.1 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Region
8.4.1 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2016-2027)
9.2 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
9.2.1 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2027)
9.3 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application
9.3.1 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2027)
9.4 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country
9.4.1 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type
10.2.1 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application
10.3.1 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country
10.4.1 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
11.1.4 Pfizer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
11.2.4 Bayer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
11.3.4 Novartis Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Immunicum
11.4.1 Immunicum Company Details
11.4.2 Immunicum Business Overview
11.4.3 Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
11.4.4 Immunicum Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
11.4.5 Immunicum Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
11.5.4 Roche Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
11.5.5 Roche Recent Development
11.6 AB Science
11.6.1 AB Science Company Details
11.6.2 AB Science Business Overview
11.6.3 AB Science Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
11.6.4 AB Science Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
11.6.5 AB Science Recent Development
11.7 Arog Pharmaceuticals
11.7.1 Arog Pharmaceuticals Company Details
11.7.2 Arog Pharmaceuticals Business Overview
11.7.3 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
11.7.4 Arog Pharmaceuticals Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
11.7.5 Arog Pharmaceuticals Recent Development
11.8 Boston Biomedical
11.8.1 Boston Biomedical Company Details
11.8.2 Boston Biomedical Business Overview
11.8.3 Boston Biomedical Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
11.8.4 Boston Biomedical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
11.8.5 Boston Biomedical Recent Development
11.9 Sun Pharmaceutical
11.9.1 Sun Pharmaceutical Company Details
11.9.2 Sun Pharmaceutical Business Overview
11.9.3 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
11.9.4 Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
11.9.5 Sun Pharmaceutical Recent Development
11.10 Natco Pharma
11.10.1 Natco Pharma Company Details
11.10.2 Natco Pharma Business Overview
11.10.3 Natco Pharma Gastrointestinal Stromal Tumors (GISTs) Treatment Introduction
11.10.4 Natco Pharma Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
11.10.5 Natco Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Ablation
Table 7. Key Players of Embolization
Table 8. Key Players of Others
Table 9. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions (2016-2021)
Table 13. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions (2022-2027)
Table 15. Gastrointestinal Stromal Tumors (GISTs) Treatment Market Trends
Table 16. Gastrointestinal Stromal Tumors (GISTs) Treatment Market Drivers
Table 17. Gastrointestinal Stromal Tumors (GISTs) Treatment Market Challenges
Table 18. Gastrointestinal Stromal Tumors (GISTs) Treatment Market Restraints
Table 19. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Players (2016-2021)
Table 21. Global Top Gastrointestinal Stromal Tumors (GISTs) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment as of 2020)
Table 22. Ranking of Global Top Gastrointestinal Stromal Tumors (GISTs) Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Gastrointestinal Stromal Tumors (GISTs) Treatment Product Solution and Service
Table 26. Date of Enter into Gastrointestinal Stromal Tumors (GISTs) Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table 69. Pfizer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table 74. Bayer Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table 79. Novartis Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Immunicum Company Details
Table 82. Immunicum Business Overview
Table 83. Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table 84. Immunicum Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021) & (US$ Million)
Table 85. Immunicum Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table 89. Roche Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. AB Science Company Details
Table 92. AB Science Business Overview
Table 93. AB Science Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table 94. AB Science Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021) & (US$ Million)
Table 95. AB Science Recent Development
Table 96. Arog Pharmaceuticals Company Details
Table 97. Arog Pharmaceuticals Business Overview
Table 98. Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table 99. Arog Pharmaceuticals Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021) & (US$ Million)
Table 100. Arog Pharmaceuticals Recent Development
Table 101. Boston Biomedical Company Details
Table 102. Boston Biomedical Business Overview
Table 103. Boston Biomedical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021) & (US$ Million)
Table 104. Boston Biomedical Recent Development
Table 105. Sun Pharmaceutical Company Details
Table 106. Sun Pharmaceutical Business Overview
Table 107. Sun Pharmaceutical Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table 108. Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021) & (US$ Million)
Table 109. Sun Pharmaceutical Recent Development
Table 110. Natco Pharma Company Details
Table 111. Natco Pharma Business Overview
Table 112. Natco Pharma Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table 113. Natco Pharma Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021) & (US$ Million)
Table 114. Natco Pharma Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Targeted Therapy Features
Figure 4. Radiation Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Ablation Features
Figure 7. Embolization Features
Figure 8. Others Features
Figure 9. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Ambulatory Surgical Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Gastrointestinal Stromal Tumors (GISTs) Treatment Report Years Considered
Figure 15. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions: 2020 VS 2027
Figure 18. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Regions (2022-2027)
Figure 19. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Players in 2020
Figure 20. Global Top Gastrointestinal Stromal Tumors (GISTs) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumors (GISTs) Treatment as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue in 2020
Figure 22. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Type (2016-2021)
Figure 23. Global Gastrointestinal Stromal Tumors (GISTs) Treatment Revenue Market Share by Type (2022-2027)
Figure 24. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2016-2027)
Figure 26. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2016-2027)
Figure 27. North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Country (2016-2027)
Figure 28. United States Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2016-2027)
Figure 32. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2016-2027)
Figure 33. Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Country (2016-2027)
Figure 34. Germany Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Region (2016-2027)
Figure 44. China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2016-2027)
Figure 52. Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2016-2027)
Figure 53. Latin America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Country (2016-2027)
Figure 54. Mexico Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share by Country (2016-2027)
Figure 60. Turkey Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Pfizer Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
Figure 66. Immunicum Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
Figure 67. Roche Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
Figure 68. AB Science Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
Figure 69. Arog Pharmaceuticals Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
Figure 70. Boston Biomedical Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
Figure 71. Sun Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
Figure 72. Natco Pharma Revenue Growth Rate in Gastrointestinal Stromal Tumors (GISTs) Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---